Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity

Journal of Oncology Pharmacy Practice

Volumn 14, Issue 1, 2008, Pages 51-55

  Collier, Kathleen ^a   Schink, Cordula ^a   Young, Anna Mary ^a   How, Katharine ^a   Seckl, Michael ^a   Savage, Philip ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Etoposide; Etoposide phosphate; Hypersensitivity

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CHLORPHENIRAMINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETOPOFOS; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; VINCRISTINE; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; BRONCHOSPASM; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EMERGENCY TREATMENT; FACE; FEMALE; FLUSHING; FOLLICULAR LYMPHOMA; GERM CELL TUMOR; HUMAN; HYPERSENSITIVITY REACTION; LUNG SMALL CELL CANCER; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETREATMENT; REVIEW; SYMPTOMATOLOGY; TERTIARY HEALTH CARE; TESTIS CANCER; THORAX PAIN; TROPHOBLASTIC TUMOR; URTICARIA; VOMITING; ARTICLE; CASE REPORT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEOPLASM;

ADOLESCENT; ADULT; AGED; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CHLORPHENIRAMINE; DRUG HYPERSENSITIVITY; ETOPOSIDE; FEMALE; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; ORGANOPHOSPHORUS COMPOUNDS;

EID: 42949123574     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155207085355     Document Type: Review

References (15)

1. Williams SD, Birch R., Einhorn LH, Irwin L., Greco FA, Loehrer PJ Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987; 4: 1435-40.
2. Bower M., Newlands ES, Holden L., Short D., Brock C., Rustin GJ, Begent RH, Bagshawe KD EMA-CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997; 15: 2636-43.
3. Newlands ES, Mulholland PJ, Holden L., Seckl MJ, Rustin GJ Etoposide and cisplatin-etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA-cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000; 18: 854-59.
4. O'Dwyer PJ, Weiss RB Hypersensitivity reactions induced by etoposide. Cancer Treat Rep 1984; 68: 959-61.
5. O'Brein MER, Souberbielle BE Allergic reactions to cytotoxic drugs - an update. Annals Oncol. 1992; 3: 605-10.
6. Weiss RB Hypersensitivity reactions. In: Perry MC. editor. The chemotherapy source book. 2nd edn, Baltimore; Williams & Wilkins, 1996: 613-34.
7. Hudson MM, Weinstein HJ, Donaldson SS et al. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol 1993; 11: 1080-4.
8. Hoetelmans RM, Schornagel JH, ten Bokkel Huinink WW, Beijen JH Hypersensitivity reactions to etoposide. Ann Pharmacother 1996; 30: 367-71.
9. Siderov J., Prasad P., De Boer R., Desai J. Safe administration of etoposode phosphate after hypersensitivity reaction to intravenous etoposide. British Journal of Cancer 2002; 86: 12-13.
10. Bower M., Brock C., Gulliford T., O'Reilly, SM, Smith DB, Newlands ES A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma. Cancer Chemother Pharmacol 1996; 38: 106-09.
11. Bower M., Newlands ES, Holden L., Rustin GJ, Begent RH Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB-ACE chemotherapy. Ann Oncol 1997; 8: 477-83.
12. Fukuoka M., Furuse K., Saijo N., Nishiwaki Y., Ikegami H., Tamura T., Shimoyama M., Suemasu K. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 1991; 83: 855-61.
13. Bernstein BJ, Troner MB Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide. Pharmacotherapy 1999; 19: 989-91.
14. Tester WJ, Cohn JB, Fleekop PD, Rabinowitz MS, Lieberman JS Successful rechallenge to etoposide after an acute vasomotor response. J Clin Oncol 1990; 8: 1600-01.
15. Athanassiou AE, Bafaloukos D., Pectasides D., Dimitriadis M. Acute vasomotor response - a reaction to etoposide. J Clin Oncol 1988; 6: 1204-05.